Is the flu shot market a slam dunk for mRNA vaccines? Experts aren’t so sure
Here are two things that are true.
The world needs more effective flu vaccines. And pharmaceutical companies that learned of the vaccine-making power of the messenger RNA platform during the Covid-19 pandemic need new markets for their technology.
